道琼斯指数
51,770.31
涨跌
-572.25-1.09%
在 MEXC 探索美国生物科技板块股票,涵盖专注于药物研发、基因治疗及生物学研究的公司。比较股价、当日涨跌、市值和成交量,全面了解生物科技行业动态。

今日美股市场整体下跌,道琼斯指数下跌 1.09%,标普 500 指数下跌 1.82%,纳斯达克综合指数下跌 2.86%。市场广度偏弱,3,938 只股票下跌、1,180 只上涨,整体呈现偏空格局。
| # | 股票 | 52 周价格区间 | |||||
|---|---|---|---|---|---|---|---|
| 51 | Attovia Therapeutics, Inc.ATTO | $15.30 | -0.26% | 125.48K | $721.29M | $12.94 - $28.00 | 0.00% |
| 52 | Solid Biosciences Inc.SLDB | $6.20 | -2.97% | 721.69K | $665.12M | $3.79 - $11.45 | 0.00% |
| 53 | 4D Molecular Therapeutics, Inc.FDMT | $11.89 | -7.04% | 528.99K | $656.74M | $6.96 - $16.93 | 0.00% |
| 54 | Candel Therapeutics, Inc.CADL | $8.33 | -3.64% | 647.89K | $637.48M | $4.35 - $14.00 | 0.00% |
| 55 | Aura Biosciences, Inc.AURA | $6.14 | -2.38% | 440.20K | $636.85M | $4.73 - $9.54 | 0.00% |
| 56 | Ginkgo Bioworks Holdings, Inc.DNA | $11.24 | -12.01% | 2.39M | $622.51M | $5.37 - $18.22 | 0.00% |
| 57 | DBV Technologies S.A.DBVT | $9.49 | -7.39% | 403.69K | $596.71M | $8.63 - $26.18 | 0.00% |
| 58 | Entera Bio Ltd.ENTX | $3.19 | +2.40% | 286.57K | $554.99M | $0.91 - $4.20 | 0.00% |
| 59 | NRC HealthNRC | $23.79 | +1.23% | 68.19K | $536.17M | $11.73 - $24.40 | 0.03% |
| 60 | aTyr Pharma, Inc.ATYR | $4.95 | -6.70% | 118.53K | $485.83M | $4.07 - $44.40 | 0.00% |
| 61 | REGENXBIO Inc.RGNX | $7.21 | -2.70% | 858.99K | $475.82M | $5.46 - $16.19 | 0.00% |
| 62 | C4 Therapeutics, Inc.CCCC | $3.38 | +2.42% | 2.11M | $415.21M | $1.69 - $5.17 | 0.00% |
| 63 | Editas Medicine, Inc.EDIT | $2.67 | -9.04% | 2.65M | $409.29M | $1.66 - $3.94 | 0.00% |
| 64 | Allogene Therapeutics, Inc.ALLO | $1.18 | -6.00% | 9.12M | $405.95M | $1.04 - $4.46 | 0.00% |
| 65 | Zura Bio LimitedZURA | $4.06 | +5.45% | 3.88M | $388.78M | $3.25 - $7.44 | 0.00% |
| 66 | Tectonic Therapeutic, Inc.TECX | $19.70 | -3.73% | 115.80K | $385.12M | $15.52 - $39.53 | 0.00% |
| 67 | IRulya Therapeutics Inc.IRLA | $33.27 | +5.95% | 97.39K | $360.66M | $25.13 - $41.00 | 0.00% |
| 68 | Fennec Pharmaceuticals Inc.FENC | $10.20 | -7.12% | 159.86K | $358.45M | $5.65 - $13.25 | 0.00% |
| 69 | Kyverna Therapeutics, Inc.KYTX | $5.66 | -3.25% | 530.14K | $349.91M | $5.16 - $13.67 | 0.00% |
| 70 | Surrozen, Inc.SRZN | $29.14 | -0.95% | 206.12K | $338.34M | $11.39 - $37.83 | 0.00% |
| 71 | X4 Pharmaceuticals, Inc.XFOR | $3.35 | -0.15% | 602.44K | $332.64M | $2.43 - $4.83 | 0.00% |
| 72 | Scribe Therapeutics Inc.SCTX | $15.44 | -11.41% | 460.20K | $332.06M | $13.50 - $39.60 | 0.00% |
| 73 | Agenus Inc.AGEN | $6.83 | -3.60% | 447.46K | $308.50M | $2.71 - $10.31 | 0.00% |
| 74 | SAB Biotherapeutics, Inc.SABS | $3.36 | +4.02% | 671.93K | $305.44M | $2.44 - $5.15 | 0.00% |
| 75 | Eikon Therapeutics, Inc.EIKN | $5.31 | -0.65% | 504.49K | $300.07M | $5.01 - $17.40 | 0.00% |
| 76 | ProKidney Corp.PROK | $1.29 | -11.90% | 1.67M | $270.56M | $1.29 - $3.13 | 0.00% |
| 77 | Century Therapeutics, Inc.IPSC | $1.48 | +1.03% | 843.44K | $267.09M | $0.43 - $3.04 | 0.00% |
| 78 | Lexeo Therapeutics, Inc.LXEO | $3.14 | +2.61% | 825.21K | $257.95M | $2.55 - $10.99 | 0.00% |
| 79 | Cabaletta Bio, Inc.CABA | $1.51 | -4.10% | 3.37M | $256.86M | $1.32 - $4.23 | 0.00% |
| 80 | Fate Therapeutics, Inc.FATE | $2.08 | -3.92% | 985.61K | $249.83M | $0.95 - $3.23 | 0.00% |
| 81 | Alector, Inc.ALEC | $2.19 | -2.01% | 954.00K | $245.09M | $1.09 - $2.76 | 0.00% |
| 82 | Ocugen, Inc.OCGN | $0.71 | -4.84% | 4.71M | $240.09M | $0.69 - $2.73 | 0.00% |
| 83 | Inhibikase Therapeutics, Inc.IKT | $1.54 | -7.19% | 351.84K | $215.58M | $1.33 - $2.61 | 0.00% |
| 84 | Palisade Bio, Inc.PALI | $1.18 | -0.84% | 2.83M | $204.77M | $1.10 - $2.85 | 0.00% |
| 85 | Artiva Biotherapeutics, Inc.ARTV | $4.18 | -1.06% | 1.80M | $204.56M | $2.96 - $14.53 | 0.00% |
| 86 | Precision BioSciences, Inc.DTIL | $7.05 | -5.24% | 90.24K | $194.59M | $3.53 - $9.62 | 0.00% |
| 87 | Alpha Cognition Inc.ACOG | $8.79 | -4.35% | 45.89K | $191.45M | $4.50 - $10.14 | 0.00% |
| 88 | Invivyd, Inc.IVVD | $0.58 | -3.01% | 5.21M | $171.84M | $0.53 - $3.07 | 0.00% |
| 89 | MaxCyte, Inc.MXCT | $1.58 | -8.09% | 916.37K | $163.58M | $0.64 - $1.80 | 0.00% |
| 90 | Sutro Biopharma, Inc.STRO | $9.10 | -0.33% | 97.99K | $150.89M | $7.15 - $43.85 | 0.00% |
| 91 | Protara Therapeutics, Inc.TARA | $2.48 | -1.19% | 521.60K | $146.85M | $2.28 - $7.82 | 0.00% |
| 92 | Compass Therapeutics, Inc.CMPX | $0.79 | +4.80% | 2.58M | $142.99M | $0.73 - $6.88 | 0.00% |
| 93 | Coherus Oncology, Inc.CHRS | $0.83 | -7.32% | 2.09M | $128.08M | $0.81 - $2.62 | 0.00% |
| 94 | Outlook Therapeutics, Inc.OTLK | $0.47 | -5.51% | 4.69M | $113.93M | $0.16 - $2.54 | 0.00% |
| 95 | Humacyte, Inc.HUMA | $0.41 | -12.86% | 4.98M | $113.62M | $0.34 - $1.68 | 0.00% |
| 96 | Anavex Life SciencesAVXL | $1.19 | -8.46% | 990.42K | $109.94M | $1.14 - $8.14 | 0.00% |
| 97 | Voyager Therapeutics, Inc.VYGR | $1.72 | -2.27% | 753.22K | $105.67M | $1.68 - $5.48 | 0.00% |
| 98 | enGene Therapeutics Inc.ENGN | $1.53 | +0.65% | 1.16M | $102.87M | $1.40 - $12.25 | 0.00% |
| 99 | Black Diamond Therapeutics, Inc.BDTX | $1.77 | -4.57% | 451.22K | $101.98M | $1.60 - $4.94 | 0.00% |
| 100 | LENZ Therapeutics, Inc.LENZ | $3.04 | -12.75% | 2.16M | $95.64M | $3.00 - $32.13 | 0.00% |
| 现货美股(RealStocks) | 代币化美股(Tokenized Stocks) | 股票合约(Stock Futures) | |
|---|---|---|---|
| 是什么 | 美股上市公司的真实股份(现货美股) | 与美股/ETF 挂钩的区块链代币 | 以 USDT 保证金进行的股价合约交易 |
| 所有权 | 是 —— 真实持股 | 否 —— 仅为合成敞口 | 否 —— 仅为衍生品敞口 |
| 股东权益 | 有(如分红) | 无 | 无 |
| 交易时间 | 美股交易时段(盘前、正常、盘后、隔夜) | 24/7 全天候 | 支持交易对最高可达 24/7 全天候 |
| 持仓方式 | 买入并持有 | 买入并持有 | 支持多空双向、杠杆交易 |
| 适合人群 | 追求长期持有和分红收益的投资者 | 希望全天候获得股票敞口、无需持有股票的交易者 | 希望通过杠杆进行投机或对冲的短线/活跃交易者 |
通过 MEXC 合作的持牌券商购买真实美股,并可按适用条件享有股息等股东权益。
覆盖 7,000+ 只美国上市股票及 ETF,涵盖科技、金融、医疗、消费等多个行业。
支持 USDT 转入及 USDT/USD 转换,更便捷地为 RealStocks 账户提供资金。
以具有竞争力的交易成本参与真实美股交易,让更多资金用于投资策略。
本页面展示的美股价格、指数、排行榜、图表及其他市场数据可能来自第三方数据提供商,并可能存在延迟或误差。MEXC 提供的相关信息仅供参考和教育用途,不对其准确性或完整性作出保证。页面内容不构成任何金融或投资建议,也不构成买卖任何证券的推荐。美股交易存在风险,历史表现不代表未来结果,用户应在作出投资决定前进行独立研究。